|
|
||||||||||
|
J Am Coll Cardiol, 2002; 39:288-294 © 2002 by the American College of Cardiology Foundation |
,*



,




* National Cardiovascular Center Research Institute, Suita, Japan
Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Mibu, Japan
Division of Cardiovascular Surgery and Hypertension, National Cardiovascular Center, Suita, Japan
Division of Cardiovascular Surgery, Takarazuka Citizens Hospital, Takarazuka, Japan
|| Division of Pathology, National Cardiovascular Center, Suita, Japan
¶ Department of Cardiovascular Medicine, Okayama University Medical School, Okayama, Japan
Manuscript received April 17, 2001; revised manuscript received September 25, 2001, accepted October 24, 2001.
* Reprint requests and correspondence: Dr. Toshio Nishikimi, Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan.
nishikim{at}dokkyomed.ac.jp
OBJECTIVES: We hypothesized that the plasma atrial natriuretic peptide (ANP) level reflects atrial degenerative change and may predict the outcome of the maze procedure.
BACKGROUND: Although a larger preoperative left atrial dimension and longer duration of atrial fibrillation (AF) have been reported in patients with persistent AF than in those with sinus rhythm (SR), these individual factors were not enough to predict the outcome of the maze procedure.
METHODS: Preoperative plasma ANP levels were measured in consecutive 62 patients who underwent the Kosakais modified maze procedure. Moreover, we performed histological and molecular biological examinations in the resected left atrial tissues.
RESULTS: The preoperative plasma ANP was lower in the AF group (n = 13) than it was in the SR group (n = 49) (p < 0.001). Multiple logistic regression analysis revealed that duration of AF and plasma ANP were independently associated with postoperative cardiac rhythm. Among 41 patients with a higher plasma ANP or shorter duration of AF than the median value, SR was restored in 95% of patients. In contrast, in 21 patients with a lower plasma ANP and a longer duration of AF than the median value, SR was restored only in 48% of patients. Histological examination revealed that the collagen volume in the left atrial tissue was higher in AF than it was in SR and inversely correlated with plasma ANP. In addition, the messenger RNA expressions of ANP, collagen type I and type III were lower in AF than they were in SR.
CONCLUSIONS: These results suggest that a combination of plasma ANP and/or duration of AF may predict the success rate for the maze operation. Advanced atrial degenerative change may result in a decrease of atrial ANP secretion.
| ||||||||||||||||
This article has been cited by other articles:
![]() |
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Tziakas, G. K. Chalikias, N. Papanas, D. A. Stakos, S. V. Chatzikyriakou, and E. Maltezos Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation Europace, August 1, 2007; 9(8): 589 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Mack, F. Milla, W. Ko, L. N. Girardi, L. Y. Lee, A. J. Tortolani, J. Mascitelli, K. H. Krieger, and O. W. Isom Surgical Treatment of Atrial Fibrillation Using Argon-Based Cryoablation During Concomitant Cardiac Procedures Circulation, August 30, 2005; 112(9_suppl): I-1 - I-6. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goette and C. Rocken Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"? Eur. Heart J., July 2, 2004; 25(14): 1185 - 1186. [Full Text] [PDF] |
||||
![]() |
M. P. van den Berg, I. C. van Gelder, and D. J. van Veldhuisen Depletion of atrial natriuretic peptide during longstanding atrial fibrillation Europace, January 1, 2004; 6(5): 433 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T Sie, W. P Beukema, A. Elvan, and A. R Ramdat Misier New strategies in the surgical treatment of atrial fibrillation Cardiovasc Res, June 1, 2003; 58(3): 501 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wozakowska-Kaplon and G. Opolski Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1716 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rocken, B. Peters, G. Juenemann, W. Saeger, H. U. Klein, C. Huth, A. Roessner, and A. Goette Atrial Amyloidosis: An Arrhythmogenic Substrate for Persistent Atrial Fibrillation Circulation, October 15, 2002; 106(16): 2091 - 2097. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |